全文获取类型
收费全文 | 208篇 |
免费 | 15篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 7篇 |
基础医学 | 21篇 |
口腔科学 | 1篇 |
临床医学 | 15篇 |
内科学 | 28篇 |
皮肤病学 | 3篇 |
神经病学 | 9篇 |
特种医学 | 21篇 |
外科学 | 27篇 |
综合类 | 9篇 |
预防医学 | 12篇 |
眼科学 | 14篇 |
药学 | 12篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2021年 | 3篇 |
2020年 | 3篇 |
2019年 | 2篇 |
2018年 | 6篇 |
2017年 | 5篇 |
2016年 | 7篇 |
2015年 | 7篇 |
2014年 | 13篇 |
2013年 | 22篇 |
2012年 | 13篇 |
2011年 | 24篇 |
2010年 | 23篇 |
2009年 | 15篇 |
2008年 | 34篇 |
2007年 | 8篇 |
2006年 | 1篇 |
2004年 | 1篇 |
2003年 | 3篇 |
1999年 | 2篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有224条查询结果,搜索用时 437 毫秒
91.
92.
93.
94.
95.
Eleni Th. Petridou Nadya Dimitrova Sultan Eser Denis Kachanov Hulya Karakilinc Svetlana Varfolomeeva Maria Belechri Margarita Baka Maria Moschovi Sofia Polychronopoulou Fani Athanasiadou-Piperopoulou Ioanna Fragandrea Eftichia Stiakaki Apostolos Pourtsidis Christodoulos Stefanadis Jan-Willem Coebergh Theodoros N. Sergentanis 《Cancer causes & control : CCC》2013,24(6):1111-1118
Purpose
Within Europe, incidence and mortality rates of childhood leukemia and lymphoma are rather heterogeneous. The present study comprising data from five Southern and Eastern European Cancer Registries aims to compare time trends and examine whether sociodemographic variables, clinical parameters, and proxies of efficient care affect survival.Methods
Data spanning 1996–2010 were obtained for a total of 3,041 newly diagnosed childhood leukemia and 1,183 lymphoma cases reported by the Greek Nationwide Registry for Childhood Hematological Malignancies, Bulgarian National Cancer Registry, Moscow Region and Turkey (Antalya and Izmir) Cancer Registries. Poisson modeling for the evaluation of time trends and multivariate Cox regression analysis for the assessment of prognostic factors were performed.Results
The incidence of leukemia was increasing in all cases, with Bulgaria and Greece presenting statistically significant annual changes (+3.5, and +1.7 %, respectively), followed by marginally increasing trends in Izmir and Moscow; by contrast, there was a remarkable, statistically significant, decreasing mortality trend for leukemia. Rates for lymphoma remained flat. Greece experienced almost twofold better survival rates for both leukemia and lymphoma, probably due to its higher socioeconomic status during the study period. Overall, patients with leukemia living in rural areas had a 28 % lower prognosis (RR: 1.28, 95 % CI 1.03–1.59), pointing to effects of remoteness, when the most privileged country (Greece) was excluded from the analysis.Conclusions
The favorable mortality trends highlight the progress in Southern–Eastern European countries along their trajectory to converge with Northern–Western EU counterpart states. Socioeconomic status may act as a multipotent factor underlying the study findings. 相似文献96.
Spyros P. Gialamas Theodoros N. Sergentanis Constantine N. Antonopoulos Nick Dessypris George P. Chrousos Eleni Th. Petridou 《Cancer causes & control : CCC》2013,24(12):2129-2141
Purpose
Equivocal results regarding the role of leptin in colorectal cancer (CRC) and adenoma (CRA) have been reported. A case–control study investigating the association of leptin with CRC risk and clinicopathological characteristics along with meta-analysis of published data on both CRC and CRA were conducted.Methods
Pubmed and Embase were searched for the meta-analysis, comprising 28 case–control studies amounting 3,614 CRC and 1,215 CRA cases, along with 5,220 controls. Meticulous contact with the authors of individual studies was undertaken for the provision of additional data. Pooling of standardized mean differences (SMD), relative risks (RR) and 95 % CI (random effects models), subgroup, sensitivity, and meta-regression analyses were conducted.Results
The meta-analysis suggested positive association of serum leptin with CRA (RR, 95 % CI 1.35, 1.03 to +1.76), but not CRC either at the pooled analysis on SMDs or RRs (SMD, 95 % CI 0.18, ?0.04 to +0.40; RR, 95 % CI 1.04, 0.65 to +1.65). Significant heterogeneity between studies on CRC as well as between studies on CRA providing SMD was noted. Subgroup, meta-regression and sensitivity analyses highlighted potential methodology-, design-, size- and quality-related effect modifiers.Conclusions
Meta-analysis of current evidence suggests positive association of serum leptin with CRA but not with CRC risk. Given the case–control nature of available studies, the limited number of studies on serum leptin and CRA, and the heterogeneity of CRC studies, carefully designed, prospective studies preferably reporting RRs adjusted for a variety of confounders may be warranted. 相似文献97.
98.
99.
100.